Jinxue Wei
Biographic Data
| ID | 7371295 |
|---|---|
| NAME | Jinxue Wei |
| GIVEN NAMES | Jinxue |
| FAMILY NAME | Wei |
| SIGNATURE | WEI J |
| AFFILIATIONS | Sichuan University |
| ORCID | 0000-0002-6727-2655 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Relationship of prefrontal cortex activity with anhedonia and cognitive function in major depressive disorder
These findings indicate that changes in prefrontal lobe oxygenated hemoglobin levels, a region implicated in hedonic motivation and cognitive function, may serve as potential biomarkers for interventions targeting individuals with MDD. Our results corroborate the clinical consensus that the prefrontal cortex is a primary target for non-invasive neuromodulatory treatments for depression
Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder
Our research shows decreased circulating neuropeptides have the potential to differentiate severe mental illnesses from controls. These neuropeptides are promising treatment targets for improving clinical symptoms and cognitive function in FES, BD, and MDD
A Whole Transcriptome Analysis in Peripheral Blood Suggests That Energy Metabolism and Inflammation Are Involved in Major Depressive Disorder
Our results suggested that the processes of energy metabolism and inflammation may be involved in the pathophysiology of MDD
Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
Background: Major depressive disorder (MDD) is a common disease which is complicated by metabolic disorder. Although MDD has been studied relatively intensively, its metabolism is yet to be elucidated. Methods: To profile the global pathophysiological processes of MDD patients, we used metabolomics to identify differential metabolites and applied a new database Metabolite set enrichment analysis (MSEA) to discover dysfunctions of metabolic pathwa…
Genome-Wide Expression Analysis Reveals Diverse Effects of Acute Nicotine Exposure on Neuronal Function-Related Genes and Pathways
Previous human and animal studies demonstrate that acute nicotine exposure has complicated influences on the function of the nervous system, which may lead to long-lasting effects on the behavior and physiology of the subject. To determine the genes and pathways that might account for long-term changes after acute nicotine exposure, a pathway-focused oligoarray specifically designed for drug addiction research was used to assess acute nicotine ef…
No prominent works on this page.
Genome-Wide Expression Analysis Reveals Diverse Effects of Acute Nicotine Exposure on Neuronal Function-Related Genes and Pathways
Previous human and animal studies demonstrate that acute nicotine exposure has complicated influences on the function of the nervous system, which may lead to long-lasting effects on the behavior and physiology of the subject. To determine the genes and pathways that might account for long-term changes after acute nicotine exposure, a pathway-focused oligoarray specifically designed for drug addiction research was used to assess acute nicotine ef…
Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
Background: Major depressive disorder (MDD) is a common disease which is complicated by metabolic disorder. Although MDD has been studied relatively intensively, its metabolism is yet to be elucidated. Methods: To profile the global pathophysiological processes of MDD patients, we used metabolomics to identify differential metabolites and applied a new database Metabolite set enrichment analysis (MSEA) to discover dysfunctions of metabolic pathwa…
A Whole Transcriptome Analysis in Peripheral Blood Suggests That Energy Metabolism and Inflammation Are Involved in Major Depressive Disorder
Our results suggested that the processes of energy metabolism and inflammation may be involved in the pathophysiology of MDD
Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder
Our research shows decreased circulating neuropeptides have the potential to differentiate severe mental illnesses from controls. These neuropeptides are promising treatment targets for improving clinical symptoms and cognitive function in FES, BD, and MDD
Relationship of prefrontal cortex activity with anhedonia and cognitive function in major depressive disorder
These findings indicate that changes in prefrontal lobe oxygenated hemoglobin levels, a region implicated in hedonic motivation and cognitive function, may serve as potential biomarkers for interventions targeting individuals with MDD. Our results corroborate the clinical consensus that the prefrontal cortex is a primary target for non-invasive neuromodulatory treatments for depression
Major depressive disorder (4 works) · Medicine (4 works) · Bioinformatics (3 works) · Biology (3 works) · Neuroscience (3 works) · Psychiatry (3 works) · Psychology (3 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Cognition (2 works)